Arrowhead Research Corp. (ARWR)

5.69
+0.09 (+1.59%)
Exchange
NMS
Day Range
5.61 - 5.88
52 Week Range
4.35 - 17.42
Open
5.88
Avg. Vol
1,053,930
Market Cap
342.13M
Short ratio
14.75
PE ratio
PEG Ratio
-0.49
Earnings Share
-1.61
Bid
5.74
Book Value
2.21
EPS Current Year Estimate
-1.58
EPS Estimate Next Year
-1.73
Change from Year Low
1.40
Change from Year High
-11.67
Price Target 1 Year
9.50

Complete Profile

Name Arrowhead Research Corp.
Sector Healthcare
Industry Biotechnology
Address

Arrowhead Research Corp.
225 South Lake Avenue
Suite 1050
Pasadena, CA 91101
United States - Map
Phone: 626-304-3400
Fax: 626-304-3401
Website: http://www.arrowheadresearch.com

Employees 81
Executives Dr. Christopher R. Anzalone Ph.D.
Chief Exec. Officer Pres Director Chief Exec. Officer of Calando Chief Exec. Officer of Tego Chief Exec. Officer of Nantope Chief Exec. Officer of Leonardo and Chief Exec. Officer of Ablaris Therapeutics


Mr. Kenneth A. Myszkowski CPA
Chief Financial Officer


Dr. Bruce D. Given M.D.
Chief Operating Officer


Dr. David L. Lewis Ph.D.
Chief Scientific Officer


Mr. Peter B. Leone MBA
VP of Strategy & Program Management


Holders
  • Oppenheimer Global Opportunities Fund
  • Fidelity Select Portfolios - Biotechnology
  • Vanguard Total Stock Market Index Fund
  • iShares Russell 2000 ETF
  • JP Morgan Small Cap Growth Fund
  • Vanguard Extended Market Index Fund
  • iShares Russell 2000 Growth ETF
  • JP Morgan U.S. Small Company Fund
  • Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I
  • College Retirement Equities Fund-Stock Account